Opportunity Information: Apply for PAR 12 039
Apply for PAR 12 039
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Small Grants Program for Cancer Epidemiology (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.399 Cancer Control.
- This funding opportunity was created on Nov 30, 2011 and posted on Nov 28, 2011.
- Applicants must submit their applications by Nov 18, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $50,000.00 in funding.
- Eligible applicants include: Special district governments Native American tribal governments (Federally recognized) Private institutions of higher education City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education County governments Small businesses State governments Independent school districts.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Small Grants Program for Cancer Epidemiology (R03), funding opportunity number PAR-12-039, is a National Cancer Institute (NCI) grant opportunity under the National Institutes of Health (NIH) that supports small, focused research projects aimed at improving what is known about cancer causes and patterns in populations. The program is designed around the NIH R03 mechanism, which is typically used to fund short, targeted studies that can quickly generate preliminary data, explore promising ideas, or refine methods before investigators pursue larger-scale research support. In practical terms, this opportunity is meant to help researchers take an important next step in cancer etiology and epidemiology without needing the scope or budget of a major multi-year project.
The scientific focus centers on cancer etiology (factors that cause or contribute to cancer) and cancer epidemiology (how cancer is distributed across populations and what influences risk). The announcement emphasizes several types of projects that fit especially well within an R03. These include pilot and feasibility studies that test whether a new research question or approach is workable; testing of new techniques that could improve how cancer risk factors are identified or measured; secondary analyses of existing datasets, which can be a cost-effective way to answer new questions using previously collected information; and the development or validation of measurement methods, such as improving the accuracy and reliability of questionnaires, biomarkers, exposure assessments, or other tools used to study cancer risk. The FOA also highlights interest in work that links genetic polymorphisms (common genetic variations) with other variables related to cancer risk, supporting studies that integrate genetic information with behavioral, environmental, clinical, or demographic data. Overall, the intention is to encourage innovative, well-defined projects that can serve as building blocks for more comprehensive future research in cancer etiology and epidemiology.
Administratively, this is a discretionary grant program with no cost-sharing or matching requirement. The award ceiling listed is $50,000, indicating that proposed budgets are expected to remain modest and aligned with the small-grant intent. The program is tied to CFDA numbers 93.393 (Cancer Cause and Prevention Research) and 93.399 (Cancer Control), reflecting its placement within NCI and NIH cancer research portfolios. The opportunity was posted on November 28, 2011, created on November 30, 2011, and had an original and current closing date of November 18, 2014, with an archive date of December 19, 2014, meaning it is no longer active as written and is maintained as a historical announcement.
Eligibility is broad and includes many types of domestic U.S. organizations as well as non-U.S. entities. Eligible applicants include public and private institutions of higher education, nonprofits (both 501(c)(3) and non-501(c)(3) organizations), for-profit organizations (other than small businesses), small businesses, and a wide range of government entities such as state governments, county governments, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities. The FOA also explicitly includes tribal governments and organizations, including federally recognized Native American tribal governments and other tribal organizations, as well as regional organizations and U.S. territories or possessions. In addition, the eligibility section notes several categories of institutions and organizations often emphasized in federal research funding, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and faith-based or community-based organizations. Notably, foreign institutions are eligible to apply, non-U.S. components of U.S. organizations may apply, and foreign components are allowed as defined in the NIH Grants Policy Statement, which expands opportunities for international collaboration or research conducted outside the United States when scientifically justified.
For applicants seeking the official details, the announcement points to the NIH grants guide page at http://grants.nih.gov/grants/guide/pa-files/PAR-12-039.html. For technical issues accessing the announcement or linking problems, the listed contact is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is the Small Grants Program for Cancer Epidemiology (R03)?
The Small Grants Program for Cancer Epidemiology (R03) is a National Cancer Institute (NCI) funding opportunity under the National Institutes of Health (NIH) that supports small, focused research projects intended to improve what is known about cancer causes and patterns in populations.
What is the funding opportunity number for this program?
The funding opportunity number is PAR-12-039.
Which agency offers this grant opportunity?
This opportunity is offered by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH).
What type of grant mechanism does this opportunity use?
This program uses the NIH R03 mechanism, which is commonly used to fund short, targeted studies that can generate preliminary data, explore promising ideas, or refine methods before larger-scale research is pursued.
What is the main purpose of using an R03 for cancer epidemiology work?
The intent is to help researchers take an important next step in cancer etiology and epidemiology without needing the scope or budget of a major multi-year project, while still producing useful, actionable research outputs (such as preliminary data or validated methods).
What scientific areas does PAR-12-039 focus on?
The scientific focus is on cancer etiology (factors that cause or contribute to cancer) and cancer epidemiology (how cancer is distributed across populations and what influences risk).
What types of projects are especially encouraged under this FOA?
The announcement highlights several project types that fit well within an R03, including:
- Pilot and feasibility studies
- Testing of new techniques to improve identification or measurement of cancer risk factors
- Secondary analyses of existing datasets
- Development or validation of measurement methods (questionnaires, biomarkers, exposure assessments, and related tools)
Does this opportunity support secondary analysis of existing data?
Yes. Secondary analyses of existing datasets are specifically highlighted as an example of a cost-effective approach that can answer new questions using previously collected information.
Does the FOA support measurement method development or validation?
Yes. The FOA emphasizes development or validation of measurement methods, including work to improve the accuracy and reliability of questionnaires, biomarkers, exposure assessments, or other tools used to study cancer risk.
Does this opportunity encourage research that integrates genetic information?
Yes. The FOA highlights interest in work that links genetic polymorphisms (common genetic variations) with other variables related to cancer risk, including behavioral, environmental, clinical, or demographic data.
What is the maximum award amount (award ceiling) listed for this program?
The award ceiling listed is $50,000, reflecting the small-grant intent and expectation of a modest budget.
Is cost-sharing or matching required?
No. The opportunity is described as a discretionary grant program with no cost-sharing or matching requirement.
What CFDA numbers are associated with this opportunity?
The opportunity is associated with CFDA numbers 93.393 (Cancer Cause and Prevention Research) and 93.399 (Cancer Control).
When was this opportunity posted and when did it close?
It was posted on November 28, 2011, created on November 30, 2011, and the original and current closing date listed is November 18, 2014.
Is PAR-12-039 still active?
No. The archive date is December 19, 2014, which indicates the announcement is no longer active as written and is maintained as a historical funding opportunity.
Where can applicants find the official NIH Grants Guide listing for this FOA?
The announcement points to the NIH Grants Guide page at: http://grants.nih.gov/grants/guide/pa-files/PAR-12-039.html
Who is eligible to apply?
Eligibility is broad and includes many types of domestic U.S. organizations as well as non-U.S. entities. Eligible applicants include public and private institutions of higher education, nonprofits (501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), small businesses, and numerous government entities.
Are state and local governments eligible?
Yes. The FOA lists government entities such as state governments, county governments, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities as eligible.
Are tribal governments and tribal organizations eligible?
Yes. The FOA explicitly includes federally recognized Native American tribal governments and other tribal organizations.
Are U.S. territories or possessions eligible?
Yes. The eligibility language includes U.S. territories or possessions.
Are foreign institutions eligible to apply?
Yes. The FOA states that foreign institutions are eligible to apply.
Are non-U.S. components of U.S. organizations eligible?
Yes. The FOA notes that non-U.S. components of U.S. organizations may apply.
Are foreign components allowed as part of an application?
Yes. Foreign components are allowed as defined in the NIH Grants Policy Statement, supporting international collaboration or research conducted outside the United States when scientifically justified.
Does the FOA mention specific institution types that are encouraged or included?
Yes. The eligibility section notes categories often emphasized in federal research funding, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and faith-based or community-based organizations.
Who should be contacted for technical issues accessing the announcement?
For technical issues accessing the announcement or linking problems, the listed contact is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
What kinds of research outcomes is this program designed to support?
Based on the R03 emphasis described, the program is designed to support well-defined, innovative projects that can quickly generate preliminary data, test feasibility, refine methods, or otherwise serve as building blocks for more comprehensive future research in cancer etiology and epidemiology.
Browse more opportunities from the same category: Education Health
Next opportunity: Second Chance Act Demonstration Field Experiment Fostering Desistance through Effective Supervision
Previous opportunity: Limited Competition Alzheimers Disease Cooperative Study (U19)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 12 039
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 12 039) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research to Advance Vaccine Safety (R01) Apply for PA 12 037 Funding Number: PA 12 037 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research to Advance Vaccine Safety (R21) Apply for PA 12 038 Funding Number: PA 12 038 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| International Research Collaboration on Drug Abuse and Addiction Research (R01) Apply for PA 12 040 Funding Number: PA 12 040 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| International Research Collaboration on Drug Abuse and Addiction Research (R21) Apply for PA 12 041 Funding Number: PA 12 041 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| International Research Collaboration on Drug Abuse and Addiction Research (R03) Apply for PA 12 042 Funding Number: PA 12 042 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Limited Competition Competitive Revision for Technology Development within Biomedical Technology Research Centers (P41) Apply for PAR 12 046 Funding Number: PAR 12 046 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Cancer Education Grants Program (R25) Apply for PAR 12 049 Funding Number: PAR 12 049 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Palliative Care and End of Life in People Living with HIV/AIDS(R01) Apply for RFA NR 12 004 Funding Number: RFA NR 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Palliative Care and End of Life in People Living with HIV/AIDS (R21) Apply for RFA NR 12 005 Funding Number: RFA NR 12 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Limited Competition Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54) Apply for PAR 12 055 Funding Number: PAR 12 055 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition The Medical Education Partnership Initiative Linked Awards (MEPI) (R25) Apply for RFA TW 11 004 Funding Number: RFA TW 11 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| The Chernobyl Tissue Bank Coordinating Center (Limited Competition U24) Apply for RFA CA 12 501 Funding Number: RFA CA 12 501 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Apply for PAR 12 050 Funding Number: PAR 12 050 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) Apply for PAR 12 051 Funding Number: PAR 12 051 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Patient Oriented Research Career Development Award to Promote Diversity (K23) Apply for PAR 12 052 Funding Number: PAR 12 052 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Maternal Nutrition and Pre pregnancy Obesity Effects on Mothers, Infants and Children (R01) Apply for PA 12 061 Funding Number: PA 12 061 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The NCI Transition Career Development Award to Promote Diversity (K22) Apply for PAR 12 062 Funding Number: PAR 12 062 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Early Stage Innovative Technology Development for Cancer Research (R21) Apply for RFA CA 12 002 Funding Number: RFA CA 12 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Validation and Advanced Development of Emerging Technologies for Cancer Research (R33) Apply for RFA CA 12 003 Funding Number: RFA CA 12 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Innovative and Early Stage Development of Emerging Technologies in Biospecimen Science (R21) Apply for RFA CA 12 004 Funding Number: RFA CA 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 12 039", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.